Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Global equities tumble as Federal Reserve signals higher rates for longer, triggering a broad selloff across risk ass...
A growing investing approach aims to fund car replacements with a dividend-driven portfolio, potentially ending auto ...
Rivian ranks at the bottom of the JD Power 2026 Initial Quality Study, recording 246 problems per 100 vehicles in the...
As 2028 approaches, pre-retirees face a pivotal window to optimize savings, reduce risk, and improve retirement incom...
A high-profile crypto policy debate erupts as Eli Ben-Sasson questions Bitcoin’s 21 million cap and proposes a fixed ...
Nvidia dominates today’s AI data centers, but the real threat to its throne may be a risk that sits in plain sight. T...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
AT&T tells CNBC that Starlink faces a late-arrival risk, citing a fiber-first moat and evolving wireless growth. The ...
A wave of lawsuits accusing social media platforms of harming children's mental health is moving into high-stakes cou...
Argentina presses ahead with sweeping reforms, betting on privatizations and tighter budgets. Investors are turning t...
As geopolitical tensions rise, energy prices and cyber threats intensify. This could push firms toward poly-national ...